BED BATH & BEYOND INC. REPORTS FISCAL 2021 FOURTH QUARTER RESULTS (ENDING FEBRUARY 26th, 2022)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St futures rise on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Goldman Sachs on Bed Bath & Beyond (BBBY): 'sizable miss to our expectations', Says of Co Bonds 'We expect the market reaction to be quite negative'
April 13, 2022 8:58 AM EDTGoldman Sachs analyst Kate McShane reiterated a Sell rating and $14.00 price target on Bed Bath & Beyond (NASDAQ: BBBY).
The analyst comments "BBBY reported 4Q21 adj. EPS of ($0.92), much below Consensus (Reuters) of $0.03, with a comp decline of 12%, vs GS/ Consensus estimates of -8%/-9%. The Bed, Bath & Beyond banner witnessed a comp decline of 15%, while there was growth of low single digits for the buybuy Baby banner compared to mid teen growth for the banner in 3Q21.... More
Bed Bath & Beyond (BBBY) Misses Q4 EPS by 95c
April 13, 2022 7:31 AM EDTBed Bath & Beyond (NASDAQ: BBBY) reported Q4 EPS of ($0.92), $0.95 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $2.05 billion versus the consensus estimate of $2.07 billion.
Fiscal 2022 Outlook Commentary:
At this time, the Company is providing the following... More
